pharmacy€¦ · • empowering community • intensify collaboration this strategic plan was...

1

www.pharmacy.gov.my

PHARMACEUTICAL SERVICES DIVISIONMinistry of Health MalaysiaLot 36, Jalan Universiti46350 Petaling JayaSelangor

T 03-7841 3200 F 03-7968 2222

PHARMACEUTICAL SERVICES DIVISIONMinistry of Health Malaysia

PHARMACYPROGRAMMESTRATEGIC PLAN

PHARMACY PROGRAMME STRATEGIC PLAN

2017-20202

1

The Ministry of Health is pleased to present the Pharmacy Programme Strategic Plan which sets into motion a four-year programme mapping the way forward. The plan outlines their strategic

vision supported by the core thrusts, strategies and initiatives that are synergistically moulded in order to achieve the mission and vision of the Pharmacy Programme.

The plan addresses the need to provide sustainable, high-quality pharmacy services in a complex and evolving environment. The plan clearly defines the direction of the Programme and sets priorities for action that can be implemented at national, regional and local levels.

The Pharmacy services play an integral role in the healthcare service delivery system. It offers a wide range of services spanning from primary and secondary care and enforcement of law that includes, but not limited to pharmaceutical products and cosmetics. The Pharmacy plan also supports the pharmaceutical industry by providing the regulatory backbone to ensure further growth and expansion of this vital and dynamic sector. Greater collaboration and cooperation between the various healthcare stakeholders will boost the country’s economy and improve quality of life for all.

I wish to sincerely acknowledge the dedication and effort of all who have participated in the development of this plan under the leadership of the Senior Director of the Pharmaceutical Services for the formulation of the 2017-2020 Pharmacy Programme Strategic Plan. I am certain that the success of the plan will have a positive impact on our robust healthcare system. Together we will strive towards improving the country’s healthcare needs.

DATUK DR. NOOR HISHAM BIN ABDULLAHDIRECTOR GENERAL OF HEALTHMINISTRY OF HEALTH MALAYSIA

FOREWORD


2017-20202

The Eleventh Malaysia Plan (2016-2020) has mapped the last leg of our path to reach Vision 2020. Accordingly, the Ministry of Health (MOH) has charted the way forward for the nation’s health services

through the MOH Strategic Plan 2016-2020 as well as the Health Transformation Plan to support the national agenda in achieving better health for the nation.

It is imperative for us to develop our strategic plan to guide the organisation towards achieving a common goal. With the overarching National Medicines Policy, key strategies are drawn up by analysing the current situation, our strengths and weaknesses and projecting the future needs.

As part of the team that will carry out this mission, the Pharmaceutical Services Programme MOH is focused on intensifying customer engagement in order to reach a wider population and increasing public awareness on their roles and responsibilities towards health. From the organisation aspect, we will improve operational excellence where resources will be used optimally to ensure responsive, efficient service and effective policy implementation.

The Pharmaceutical Services Programme is committed to stay ahead and keep up with changing times. Implementation of innovative pharmacy service delivery and the strengthening of ICT system readiness will create value for the customers and enhance the future delivery of healthcare to the nation. Innovation in pharmacy services will be supported mainly by initiatives in ICT-based systems such as PhIS, MyPharma-C and Quest 3+ by the National Pharmacy Regulatory Agency. Translation of research findings into the development of policy and practice are crucial for efficient organisation management and ensuring subsequent actions taken by the Programme are beneficial to the nation. We will also commit to boosting capability building by focusing on skills and knowledge enhancement in new areas as well as developing expertise in various pharmacy fields.

I believe, with the collaborated effort from all, we will implement this plan successfully and overcome the challenges and issues in the future. Let us work together as a team to achieve better health for the nation.

DR. SALMAH BINTI BAHRI, RPh 783SENIOR DIRECTOR OF PHARMACEUTICAL SERVICES PROGRAMMEMINISTRY OF HEALTH MALAYSIA

FOREWORD

3

FOREWORD

The Pharmacy Programme Strategic Plan (2017-2020) is an important document that determines the direction of the Pharmacy Programme in carrying out its role in accordance with

the aspirations of the government. This strategic plan is an initial step to ensure the development of Pharmacy Programme which is in line with the government and the ministry’s mission and vision in strengthening the health system transformation.

The Strategic Plan focuses on four main aspects, namely strengthening the governance of Pharmacy Programme, strengthening service delivery through innovation and technology, strengthening the skills, expertise and human resource capacity, and enhancing cooperation with stakeholders and empowering communities on quality use of medicines. The strategies and initiatives outlined in this plan will also have an impact on the development of pharmacy services in the future. In carrying out this mission, every member of Pharmacy Programme should instil and uphold the shared values and leadership practices identified in this document.

Finally, I would like to extend my earnest appreciation to all parties involved in the realization of this strategic plan. I hope that every member of the Pharmacy Programme is fully committed to the success of this plan.

DR. RAMLI BIN ZAINAL, RPh 1045DIRECTOR OF PHARMACY POLICY AND STRATEGIC PLANNING DIVISIONMINISTRY OF HEALTH MALAYSIA


2017-20204

The Pharmacy Programme of the Ministry of Health (MOH), established in 1951, is the lead agency that ensures the public gets access to safe, efficacious and quality pharmaceutical products, protecting their interest via enforcement of relevant legislations, and ensuring rational use of medicines by both healthcare providers and patients.

The Programme consists of five main divisions headed by a Senior Director of Pharmaceutical Services. These five main Divisions are Pharmacy Policy and Strategic Planning Division, Pharmacy Practice and Development Division, Pharmacy Enforcement Division, National Pharmaceutical Regulatory Agency (NPRA) and Pharmacy Board Malaysia. Each division plays important roles in different aspects and approaches with the same objective that is giving the best professional pharmacy service to the public.

Pharmacy Programme Strategic Plan 2017-2020 outlines the strategic directions of the Pharmacy Programme for a period of 4 years with four main focuses:

INTRODUCTION

5

MOH• Strengthen delivery of

healthcare (primary care)• Health system governance• Empowering community• Intensify collaboration

This strategic plan was developed with a view to the future direction of Pharmacy Programme in aligning with the needs and the current situation of the government’s plans. The fundamentals of this strategic plan are based on:

Strategic Thrust 2 of 11th Malaysia Plan

Improving well being for all• Priority focus area

is to achieve universal accessto quality healthcare

Health Services Transformation Plan (HSTP), Ministry of Health, Malaysia

• Developing talented health workforce

• Strengthening health policies and public organisational capacity

• Enhancing health services delivery

• Intensify health collaboration

• Inculcate corporate culture values

Ministry of Health (MOH) Strategic Plan

2016-2020• Strengthening the

healthcare service delivery especially in the primary healthcare

• Strengthening health systems governance and organisational capabilities

• Empowering individuals, families, the community toward better health awareness

• Intensify the collaboration between the public, private and NGO

Malaysian National Medicines Policy (MNMP),

2013-2020Malaysian National Medicines Policy (MNMP) objective is to promote equitable access and rational use of safe, effective and affordable essential medicines of good quality to improve health outcomes of the nations. Five core components in MNMP are:• Governance in Medicines• Access to Medicines• Quality, Safety and Efficacy

of Medicines• Quality Use of Medicines• Partnership and

Collaboration for the Healthcare Industry

A B C D

11th MALAYSIAN PLANAchieving universal access to quality healthcare

MNMPEquitable access & rational use of safe, effective & affordable medicines of good quality to improve health outcomes of the people

HSTP• Revitalising capability building• Re-engineering organisations• Enhancing service delivery• Intensify collaboration• Enculturing corporate culture

STRATEGIC PLANALIGNMENT


2017-20206

PHARMACYENFORCEMENT

DIVISIONwe will

• Ensure all sales, supply, possession and advertising of

substances, products andcosmetics are in

compliance with thelegal provisions.

PHARMACYPRACTICE &

DEVELOPMENT DIVISIONwe will

• Ensure continuous access to the quality, safe and cost-effective medicines.

• Strengthen the quality and rational use of medicines towards the better health.

• Enhance pharmaceutical careservices in line with the good

standards and practices.

POISONS ACT 1952 • Poisons Regulations 1952• Poisons (Fees) Regulations 1983• Poisons (Psychotropic

Substances) Regulations 1989

SALE OF DRUGS ACT 1952• Control of Drugs

and Cosmetics Regulations 1984

REGISTRATION OF PHARMACISTS ACT 1951• Registration of Pharmacists

Regulations 2004

MEDICINES (ADVERTISEMENT AND SALE) ACT 1956• Medicine

Advertisements Board Regulations 1976

POISONS (SODIUM HYDROXIDE) REGULATIONS 1962

SALE OF DRUGS (CERTIFICATE OF ANALYSIS) REGULATIONS 1997

PHARMACYPOLICY & STRATEGICPLANNING DIVISION

we will• Develop policies for the

pharmaceutical sector in line with the needs of national healthcare.

• Ensure excellent and efficient resources management.

PHARMACYBOARD OF MALAYSIA

we will• Ensure the registration of pharmacists

and bodies corporate complies withRegistration of Pharmacists Act 1951

and its regulations.• Set the standard for conduct, ethics,

proficiency, education and trainingand Continuous Professional

Development (CPD).

NATIONALPHARMACY

REGULATORY AGENCYwe will

• Ensure that products approved for the local market are safe and of quality and also ensure that natural

products and cosmetics aresafe and of quality.

DIVISIONS’OBJECTIVES

RELATEDACTS ANDREGULATIONS


2017-20206

7

OUR

VISI

ON

OUR

MIS

SION

4 ST

RATE

GIC

THRU

STS

Impl

emen

t inn

ovat

ive

phar

mac

y se

rvic

e de

liver

y

ICT-

base

d se

rvic

e in

nova

tion

Enha

nce

rese

arch

and

kn

owle

dge

shar

ing

Enha

nce

busi

ness

pro

cess

and

pr

oduc

t saf

ety

We

aim

to u

phol

d le

gisl

atio

ns a

nd im

prov

e po

licie

s to

en

sure

qua

lity

of p

harm

aceu

tical

pro

duct

s an

d se

rvic

esW

e ai

m to

ens

ure

effe

ctiv

e an

d re

spon

sive

org

anis

atio

nal

syst

em to

war

ds s

usta

inab

le q

ualit

y se

rvic

es

We

aim

to b

uild

cap

abili

ties

and

prof

essi

onal

ism

thro

ugh

tale

nt d

evel

opm

ent a

nd w

orkf

orce

em

pow

erm

ent

We

aim

to in

tens

ify c

olla

bora

tion

tow

ards

bes

t pra

ctic

es

and

stan

dard

s

Impr

ove

acce

ssib

ility

of

phar

mac

eutic

al p

rodu

cts

Impr

ove

effic

ienc

y an

d op

timis

e ex

pend

iture

Stre

ngth

en m

onito

ring

activ

ities

of

unre

gist

ered

pro

duct

s

Stre

ngth

en g

over

nanc

e an

d re

gula

tory

con

trol

Enha

nce

orga

nisa

tiona

l effi

cien

cy

Enha

nce

hum

an re

sour

ce

com

pete

ncy

and

perfo

rman

ce

Optim

ise

hum

an re

sour

ce

capa

city

to e

nsur

e co

ntin

uous

se

rvic

e de

liver

y

Enha

nce

mul

ti se

ctor

en

gage

men

t tow

ards

bet

ter

heal

th a

war

enes

s

Enha

nce

valu

e pr

opos

ition

of

phar

mac

y se

rvic

es

EFFI

CIEN

T

INNO

VATI

ON D

RIVE

NTr

ansl

atin

g id

eas

and

inno

vatio

ns in

to

serv

ice

that

cre

ates

val

ue fo

r our

cu

stom

ers.

OPER

ATIO

NAL

EXCE

LLEN

CETh

e el

emen

t of a

n or

gani

satio

nal

lead

ersh

ip th

at a

pplie

s a

varie

ty o

f pr

inci

ples

, sys

tem

s to

war

ds a

su

stai

nabl

e im

prov

emen

t of k

ey

perfo

rman

ce m

atrix

.

CAPA

BILI

TY B

UILD

INGS

Proc

ess

of d

evel

opin

g an

d st

reng

then

ing

the

skill

s, a

bilit

ies

and

reso

urce

s th

at

orga

nisa

tions

nee

d to

ada

pt a

nd th

rive

in a

cha

ngin

g en

viro

nmen

t.

CUST

OMER

ENG

AGEM

ENT

The

qual

ity o

f the

cus

tom

er

expe

rienc

e th

at e

mph

asis

es th

e po

sitiv

e as

pect

s of

the

inte

ract

ion

with

our

org

anis

atio

n.

TEAM

WOR

KCU

STOM

ER C

ARE

INTE

GRIT

YPR

OFES

SION

ALIS

ME

SHAR

ED V

ALUE

S

ENCO

URAG

E TH

EHE

ART

ENAB

LE O

THER

STO

ACT

CHAL

LENG

ETH

E PR

OCES

SIN

SPIR

E A

SHAR

ED V

ISIO

NM

ODEL

THE

WAY

LEAD

ERSH

IP P

RACT

ICES

To e

nhan

ce th

e na

tion’

s he

alth

thro

ugh

exce

llenc

e in

the

prac

tice

of p

harm

acy

7PH

ARM

ACY P

RO

GRAM

ME S

TRATEG

IC P

LAN

2017-2

020


2017-20208

CU

STO

MER

EN

GA

GEM

EN

TTH

E QU

ALIT

Y OF

THE

CUS

TOM

ER E

XPER

IENC

E TH

AT E

MPH

ASIS

ES T

HE P

OSIT

IVE

ASPE

CTS

OF T

HE IN

TERA

CTIO

N W

ITH

OUR

ORGA

NISA

TION

Stra

tegy

Initi

ativ

eSt

rate

gy/In

itiat

ive

Deta

ilsPe

rfor

man

ce In

dica

tor

Targ

et b

y Ye

ar 2

020

STRA

TEGY

1:

Enha

nce

Mul

ti Se

ctor

En

gage

men

t Tow

ards

Be

tter H

ealth

Aw

aren

ess

Num

ber o

f Eng

agem

ent

Initi

ativ

e 1:

Enga

gem

ent w

ith lo

cal c

ounc

il in

redu

cing

una

ppro

ved

med

ical

ad

verti

sem

ent

To c

ondu

ct d

ialo

gue

sess

ions

fo

llow

ed b

y jo

ined

ope

ratio

ns

to w

ithdr

aw il

lega

l med

icin

e ad

verti

sem

ents

OPS

3B

Perc

enta

ge o

f PBT

cov

ered

100%

Initi

ativ

e 2:

Enga

gem

ent w

ith lo

cal m

edia

in

redu

cing

una

ppro

ved

med

ical

ad

verti

sem

ent

Enga

gem

ent w

ith lo

cal R

TM’s

radi

o st

atio

n th

roug

h di

alog

ue s

essi

onPe

rcen

tage

of l

ocal

RTM

’s ra

dio

stat

ion

cove

red

100%

Initi

ativ

e 3:

En

gagi

ng N

GOs/

prof

essi

onal

so

ciet

y/ g

over

nmen

t age

ncy

to

reac

h sp

ecifi

c gr

oup

tow

ards

qu

ality

use

of m

edic

ines

(QUM

) &

cust

omer

pro

tect

ion

This

initi

ativ

e is

focu

sing

on

eng

agem

ent w

ith N

GOs/

pr

ofes

sion

al s

ocie

ty/g

over

nmen

t ag

ency

as

a co

llabo

rativ

e ef

fort

to

educ

ate

and

incr

ease

aw

aren

ess

on

Qual

ity U

se o

f Med

icin

es

Num

ber o

f NGO

/soc

iety

/ go

vern

men

t age

ncy

enga

ged

(cum

ulat

ive)

5

STRA

TEGY

2:

Enha

nce

Valu

e Pr

opos

ition

of

Pha

rmac

y Se

rvic

es

This

initi

ativ

e ai

ms

to e

nhan

ce th

e pr

omot

ion

of p

harm

acy

serv

ices

1. C

usto

mer

Per

cept

ion

on

prof

essi

on a

nd s

ervi

ce2.

Ser

vice

Upt

ake

Rate

Incr

easi

ng tr

end

Initi

ativ

e 1:

Enha

nce

prom

otio

n of

pha

rmac

y se

rvic

es

This

initi

ativ

e ai

ms

to p

rom

ote

the

avai

labi

lity

of p

harm

acy

serv

ices

in

MOH

faci

lity

in o

rder

to im

prov

e se

rvic

e up

take

Impr

ove

com

mun

ity p

erce

ptio

n to

war

ds p

harm

acy

serv

ices

and

pr

ofes

sion

al im

age

Incr

ease

d co

mm

unity

aw

aren

ess

tow

ards

ph

arm

acy

serv

ices

STRATEG

IC T

HRU

STS A

ND

PLAN

OF A

CTIO

NS

9

INN

OVATIO

N D

RIV

EN

TRAN

SLAT

ING

IDEA

S AN

D IN

NOVA

TION

S IN

TO S

ERVI

CE T

HAT

CREA

TES

VALU

E FO

R OU

R CU

STOM

ERS

Stra

tegy

Initi

ativ

eSt

rate

gy/In

itiat

ive

Deta

ilsPe

rfor

man

ce In

dica

tor

Targ

et b

y Ye

ar 2

020

STRA

TEGY

1:

Impl

emen

tatio

n of

In

nova

tive

Phar

mac

y Se

rvic

e De

liver

y

Num

ber o

f inn

ovat

ive

phar

mac

y se

rvic

es d

eliv

ery

impl

emen

ted

by

year

202

02

Initi

ativ

e 1:

Expa

nsio

n of

Inte

grat

ed D

rug

Deliv

ery

Syst

em

This

initi

ativ

e ai

ms

to in

crea

se

patie

nt a

cces

s to

thei

r med

icin

e th

roug

h va

lue

adde

d se

rvic

e an

d en

surin

g co

ntin

uity

of t

heir

med

icat

ion

supp

ly

Num

ber o

f new

cen

tres

esta

blis

hed

(incr

easi

ng tr

end)

45 c

entre

s

Initi

ativ

e 2:

Med

icin

es O

ptim

isat

ion

This

initi

ativ

e fo

cuse

s on

pat

ient

s an

d th

eir e

xper

ienc

es w

ith th

e go

als

to h

elp

patie

nts

to im

prov

e tre

atm

ent o

utco

mes

and

avo

id

taki

ng u

nnec

essa

ry m

edic

ines

, re

duce

was

tage

as

wel

l as

impr

ove

med

icat

ion

safe

ty

Perc

enta

ge o

f med

ical

war

ds

impl

emen

ting

Patie

nt O

wn

Med

icat

ions

(POM

s) P

rogr

amm

es75

% o

f med

ical

war

d in

St

ate

and

Maj

or S

peci

alis

t Ho

spita

l25

% o

f med

ical

war

d in

M

inor

Spe

cial

ist H

ospi

tal

Perc

enta

ge o

f fac

ilitie

s im

plem

entin

g Pr

ogra

m B

ekas

Uba

tAl

l Sta

te h

ospi

tal

All M

ajor

Spe

cial

ist

Hosp

ital

26 M

inor

Spe

cial

ist

Hosp

ital

30%

of H

ealth

Clin

ics

STRA

TEGY

2:

ICT-

base

d Se

rvic

e In

nova

tion

No. o

f ICT

-bas

ed s

yste

m

deve

lope

d No

. of I

CT-b

ased

sys

tem

inte

grat

ed

19 in

depe

nden

t sys

tem

s de

velo

ped

3 in

tegr

ated

sys

tem

s


2017-202010St

rate

gyIn

itiat

ive

Stra

tegy

/Initi

ativ

e De

tails

Perf

orm

ance

Indi

cato

rTa

rget

by

Year

202

0

Initi

ativ

e 1:

Busi

ness

Pro

cess

Ree

ngin

eerin

g (B

PR) o

f man

ual w

ork

proc

ess

to

ICT-

base

d

This

initi

ativ

e ai

ms

to im

prov

e ef

ficie

ncy

of s

ervi

ce d

eliv

ery

thro

ugh

trans

form

atio

n of

man

ual w

ork

proc

ess

into

onl

ine

base

d se

rvic

es

Num

ber o

f man

ual w

ork

proc

ess

inno

vate

d14

iden

tified

man

ual

proc

esse

s tra

nsfo

rmed

to

onlin

e ba

sed

serv

ice

Initi

ativ

e 2:

Inte

grat

ion

of IC

T-ba

sed

syst

ems

This

initi

ativ

e fo

cuse

s to

inte

grat

e 5

exis

ting

inde

pend

ent s

yste

ms

to im

prov

e sy

stem

s ef

ficie

ncy

and

optim

ise

data

sha

ring.

The

syst

ems

are:

- M

yPha

rma-

C-

SPIK

E-

QUES

T-

MER

s-

PhIS

/CPS

Inte

grat

ion

of th

e sy

stem

by

year

20

20

Inte

grat

ion

of :

1. M

ypha

rma-

C +

SPI

KE2.

MyP

harm

a-C

+ Q

UEST

pr

ojec

t 3.

QUE

ST +

PhI

S

Initi

ativ

e 3:

Impl

emen

tatio

n of

Ph

arm

aceu

tical

Trac

k &

Trac

e Sy

stem

Phar

mac

eutic

al Tr

ack

& Tr

ace

Syst

em is

an

initi

ativ

e to

impr

ove

patie

nt s

afet

y an

d op

timis

atio

n of

lo

gist

ic m

anag

emen

t

1st p

hase

Pha

rmac

eutic

al Tr

ack

& Tr

ace

Syst

em im

plem

ente

d by

the

year

201

9

1st p

hase

Pha

rmac

eutic

al

Trac

k &

Trac

e Sy

stem

im

plem

ente

d by

the

year

20

19

Initi

ativ

es 4

: Op

timis

atio

n of

PhI

S in

MOH

fa

cilit

ies

PhIS

is a

web

-bas

ed d

rug

man

agem

ent s

yste

m to

be

fully

ut

ilised

in a

ll M

OH fa

cilit

ies

by th

e ye

ar 2

020

Perc

enta

ge o

f ARU

(A

vaila

bilit

y, Re

liabi

lity

and

Utilis

atio

n)

100%

ava

ilabi

lity

95%

relia

bilit

y(U

tilis

atio

n: in

crem

enta

l tre

nd 2

018-

2020

)

STRA

TEGY

3:

Enha

nce

Rese

arch

and

Kn

owle

dge

Shar

ing

Num

ber o

f arti

cles

/tech

nica

l re

ports

pub

lishe

d60

arti

cles

/tech

nica

l re

ports

(incr

emen

tal t

rend

2017

-202

0)

11St

rate

gyIn

itiat

ive

Stra

tegy

/Initi

ativ

e De

tails

Perf

orm

ance

Indi

cato

rTa

rget

by

Year

202

0

Initi

ativ

e 1:

Inte

nsify

rese

arch

bas

ed o

n pr

iorit

y ar

ea id

entifi

ed

This

initi

ativ

e ai

ms

to e

ncou

rage

ph

arm

acis

ts/p

harm

acy

assi

stan

ts

to c

ondu

ct re

sear

ches

bas

ed o

n Ph

arm

acy

Prog

ram

me

Rese

arch

Pr

iorit

y Fr

amew

ork

(Sta

ndar

d, Ye

ar 2

015:

50%

)

Perc

enta

ge o

f pha

rmac

y fa

cilit

ies

with

in M

OH c

ondu

ctin

g re

sear

ch

95%

pha

rmac

y fa

cilit

ies

cond

uctin

g re

sear

ch

Initi

ativ

e 2:

Inte

nsify

kno

wle

dge

shar

ing

in re

sear

ch th

roug

h m

ultip

le

plat

form

s

This

initi

ativ

e ai

ms

to in

tens

ify

know

ledg

e sh

arin

g in

rese

arch

. Re

sear

ches

are

enc

oura

ged

to b

e pr

esen

ted

in v

ario

us p

latfo

rms

(loca

l an

d in

tern

atio

nal l

evel

)

Num

ber o

f res

earc

h pr

esen

ted

370

rese

arch

es p

rese

nted

(incr

emen

tal t

rend

2017

-202

0)

STRA

TEGY

4:

Enha

nce

Busi

ness

Pro

cess

an

d Pr

oduc

t Saf

ety

Num

ber o

f priv

ate

labo

rato

ries

reco

gnis

ed5

priv

ate

labo

rato

ries

reco

gnis

ed

Initi

ativ

e 1:

Reco

gniti

on o

f priv

ate

labo

rato

ries

(con

duct

ing

test

for

tradi

tiona

l pro

duct

s)

This

initi

ativ

e ai

ms

to re

cogn

ise

priv

ate

labo

rato

ries

with

the

capa

citie

s to

pro

vide

test

ing

for;

- He

avy

Met

al

- M

icro

bial

Con

tam

inat

ion

- Un

iform

ity o

f Wei

ght

- Di

sint

egra

tion

Num

ber o

f priv

ate

labo

rato

ries

reco

gnis

ed

5 pr

ivat

e la

bora

torie

s re

cogn

ised

Initi

ativ

e 2:

Priv

atis

atio

n of

pre

-reg

istra

tion

test

ing

for t

radi

tiona

l pro

duct

This

initi

ativ

e w

ill en

able

NPR

A to

re

depl

oy re

sour

ces

for n

ew s

ervi

ces

Regi

stra

tion

test

ing

for t

radi

tiona

l pr

oduc

ts fu

lly c

ondu

cted

by

reco

gnis

ed p

rivat

e la

bora

torie

s by

202

0

All r

egis

tratio

n te

stin

g co

nduc

ted

by p

rivat

e la

bora

torie

s by

yea

r 202

0


2017-202012

OPER

ATIO

NA

L E

XC

ELLEN

CE

THE

ELEM

ENT

OF O

RGAN

ISAT

IONA

L LE

ADER

SHIP

THA

T AP

PLIE

S A

VARI

ETY

OF P

RINC

IPLE

S, S

YSTE

MS

AND

TOOL

S TO

WAR

DTH

E SU

STAI

NABL

E IM

PROV

EMEN

TOF

KEY

PERF

ORM

ANCE

MET

RICS

Stra

tegy

Initi

ativ

eSt

rate

gy/In

itiat

ive

Deta

ilsPe

rfor

man

ce In

dica

tor

Targ

et b

y Ye

ar 2

020

STRA

TEGY

1:

Impr

ove

Acce

ssib

ility

of

Phar

mac

eutic

al P

rodu

cts

Impl

emen

tatio

n of

Pric

e Se

tting

m

echa

nism

and

pat

ient

acc

ess

sche

me

Both

initi

ated

and

im

plem

ente

d

Initi

ativ

e 1:

Impl

emen

tatio

n of

Pric

e Se

tting

m

echa

nism

Pric

e Se

tting

for m

edic

ines

will

be

done

thro

ugh

the

deve

lopm

ent o

f a

mec

hani

sm fo

r pric

e se

tting

in

coop

erat

ion

with

rele

vant

aut

horit

ies

Pric

e Se

tting

mec

hani

sm is

im

plem

ente

dPr

ice

Setti

ng M

echa

nism

s is

impl

emen

ted

by 2

019

Co

nsum

er M

edic

ine

Pric

e is

pub

lishe

d by

201

9

Initi

ativ

e 2:

Impr

ovin

g ac

cess

to a

fford

able

m

edic

ine

thro

ugh

patie

nt a

cces

s sc

hem

e (P

AS)

This

pro

gram

me

is d

esig

ned

to

impr

ove

patie

nt a

cces

s to

hig

h co

st

med

icin

es

Num

ber o

f pat

ient

acc

ess

sche

me

(PAS

) im

plem

ente

d2

sche

mes

impl

emen

ted

STRA

TEGY

2:

Impr

ove

Effic

ienc

y &

Optim

ise

Expe

nditu

re

Perc

enta

ge o

f dos

sier

rece

ived

w

ith lo

cal P

E st

udy

(10%

by

2020

)10

% o

f dos

sier

rece

ived

w

ith lo

cal P

E st

udy

Initi

ativ

e 1:

Utilis

atio

n of

loca

l Ph

arm

acoe

cono

mic

[PE]

dat

a in

the

sele

ctio

n of

med

icin

es fo

r fo

rmul

ary

listin

g

This

initi

ativ

e ai

ms

to e

ncou

rage

ph

arm

acoe

cono

mic

stu

dies

util

isin

g lo

cal d

ata

thro

ugh

esta

blis

hmen

t of

PE C

entre

Perc

enta

ge o

f dos

sier

rece

ived

w

ith lo

cal P

E st

udy

(10%

by

2020

)10

% o

f dos

sier

rece

ived

w

ith lo

cal P

E st

udy

STRA

TEGY

3:

Stre

ngth

en m

onito

ring

activ

ities

of u

nreg

iste

red

prod

ucts

No. o

f lic

ence

s pr

emis

e an

d m

edia

pl

atfo

rm m

onito

red

13St

rate

gyIn

itiat

ive

Stra

tegy

/Initi

ativ

e De

tails

Perf

orm

ance

Indi

cato

rTa

rget

by

Year

202

0

Initi

ativ

e 1:

Expa

nd th

e “D

idik

, Pan

tau

and

Serb

u (D

iPS)

” ap

proa

ch to

the

hots

pot a

reas

DiPS

: Did

ik, P

anta

u an

d Se

rbu

is

a sy

stem

atic

app

roac

h to

redu

ce

sale

s of

unr

egis

tere

d pr

oduc

ts

thro

ugh

awar

enes

s an

d su

rvei

llanc

e am

ongs

t ret

aile

rs

Perc

enta

ge o

f tar

gete

d pr

emis

es

sellin

g un

regi

ster

ed p

rodu

cts

Redu

ctio

n of

targ

eted

pr

emis

es s

ellin

g un

regi

ster

ed p

rodu

cts

by

80%

in y

ear 2

020

Initi

ativ

e 2:

Mon

itorin

g s

ales

of u

nreg

iste

red

prod

ucts

and

cos

met

ics

in

the

soci

al m

edia

and

inst

ant

mes

sagi

ng p

latfo

rms

A so

cial

med

ia a

nd in

stan

t m

essa

ging

(IM

) pla

tform

is a

W

eb-b

ased

tech

nolo

gy th

at e

nabl

es

the

deve

lopm

ent,

depl

oym

ent a

nd

man

agem

ent o

f soc

ial m

edia

and

in

stan

t mes

sagi

ng s

olut

ions

and

se

rvic

es

The

num

ber o

f soc

ial m

edia

pl

atfo

rms

and

IM p

latfo

rms

mon

itore

d 25

pla

tform

s m

onito

red

STRA

TEGY

4:

Stre

ngth

en G

over

nanc

e &

Regu

lato

ry C

ontro

l

Esta

blis

hmen

t of N

PRA

as a

ce

rtifie

d Co

nfor

mity

Ass

essm

ent

Body

(CAB

) by

2018

Initi

ativ

e 1:

Esta

blis

hmen

t of N

PRA

as a

ce

rtifie

d Co

nfor

mity

Ass

essm

ent

Body

(CAB

)

This

initi

ativ

e ai

ms

to e

nhan

ce

regu

lato

ry c

ontro

l and

gov

erna

nce

of

NPRA

in m

edic

al d

evic

e

Certi

ficat

ion

as a

CAB

Certi

fied

as a

CAB

by

Med

ical

Dev

ice

Auth

ority

by

201

8

Initi

ativ

e 2:

En

hanc

e Re

gula

tory

Con

trol

of V

acci

ne in

the

Aspe

cts

of

Labo

rato

ry Te

stin

g

This

initi

ativ

e ai

ms

to e

nhan

ce

regu

lato

ry c

ontro

l in

vacc

ine

thro

ugh

colla

bora

tion

with

iden

tified

par

tner

in

dev

elop

ing

vacc

ine

test

ing

met

hod

Vacc

ine

test

ing

met

hod

deve

lope

dTh

ree

(3) v

acci

ne te

stin

g m

etho

d de

velo

ped

by

2018

STRA

TEGY

5:

Enha

nce

Orga

nisa

tiona

l Ef

ficie

ncy

Esta

blis

hmen

t NPR

A an

d LF

M a

s St

atut

ory

Body

Fina

lisat

ion

of B

ill by

202

0


2017-202014St

rate

gyIn

itiat

ive

Stra

tegy

/Initi

ativ

e De

tails

Perf

orm

ance

Indi

cato

rTa

rget

by

Year

202

0

Initi

ativ

e 1:

Esta

blis

hmen

t of N

atio

nal

Phar

mac

eutic

al R

egul

ator

y Ag

ency

(NPR

A) a

s a

stat

utor

y bo

dy

This

initi

ativ

e fo

cuse

s on

en

hanc

ing

NPRA

effi

cien

cy th

roug

h es

tabl

ishm

ent a

s st

atut

ory

body

Fina

lisat

ion

of b

ill

Fina

lisat

ion

of b

ill as

a

stat

utor

y bo

dy b

y 20

20

Initi

ativ

e 2:

Esta

blis

hmen

t of M

alay

sia

Phar

mac

y Bo

ard

(LFM

) as

a st

atut

ory

body

This

initi

ativ

e fo

cuse

s on

en

hanc

ing

LFM

effi

cien

cy th

roug

h es

tabl

ishm

ent a

s st

atut

ory

body

Fina

lisat

ion

of b

ill

Fina

lisat

ion

of b

ill as

a

stat

utor

y bo

dy b

y 20

20

CA

PA

BIL

ITY B

UIL

DIN

GPR

OCES

S OF

DEV

ELOP

ING

AND

STRE

NGTH

ENIN

G TH

E SK

ILLS

, ABI

LITI

ES A

ND R

ESOU

RCES

THA

TOR

GANI

SATI

ONS

NEED

TO

ADAP

T AN

D TH

RIVE

IN A

CHA

NGIN

G EN

VIRO

NMEN

T

Stra

tegy

Initi

ativ

eSt

rate

gy/In

itiat

ive

Deta

ilsPe

rfor

man

ce In

dica

tor

Targ

et b

y Ye

ar 2

020

STRA

TEGY

1:

Enha

nce

Hum

an R

esou

rce

Com

pete

ncy

and

Perfo

rman

ce

Capa

bilit

y bu

ildin

g Fr

amew

ork

deve

lope

dFr

amew

ork

com

plet

ed

by 2

019

Initi

ativ

e 1:

Deve

lop

capa

bilit

y bu

ildin

g fra

mew

ork

(tech

nica

l &

man

agem

ent)

This

initi

ativ

e ai

ms

to d

evel

op a

fra

mew

ork

that

offe

r an

over

view

of

the

vario

us c

aree

r opt

ions

alo

ng w

ith

educ

atio

n an

d tra

inin

g

Capa

bilit

y bu

ildin

g fra

mew

ork

deve

lope

dFr

amew

ork

deve

lope

d by

ye

ar 2

020

15St

rate

gyIn

itiat

ive

Stra

tegy

/Initi

ativ

e De

tails

Perf

orm

ance

Indi

cato

rTa

rget

by

Year

202

0

Initi

ativ

e 2:

Expa

nsio

n of

cre

dent

ialin

g an

d pr

ivile

ging

(C&P

) act

ivity

C&P

is a

pro

gram

to c

rede

ntia

l qu

alifi

ed in

divi

dual

s in

iden

tified

ar

eas

of p

ract

ice

Area

of P

ract

ice:

- En

forc

emen

t (Cy

ber F

oren

sic)

- Cl

inic

al-

Phar

mac

y Pr

actic

e-

R&D

- Re

gula

tory

1. N

o. o

f ide

ntifi

ed a

reas

of p

ract

ice

esta

blis

hed

2. N

o. o

f qua

lified

pha

rmac

ists

be

ing

cred

entia

led

C&P

esta

blis

hed

for a

ll id

entifi

ed a

rea

of p

ract

ice

30 q

ualifi

ed p

harm

acis

ts

cred

entia

led

Initi

ativ

e 3:

Esta

blis

hmen

t of S

ubje

ct M

atte

r Ex

pert

(SM

E) P

rogr

amm

e in

ph

arm

acy

serv

ices

Subj

ect M

atte

r Exp

ert i

s a

form

of

reco

gniti

on to

an

indi

vidu

al

phar

mac

ist w

ho is

an

expe

rt in

a

parti

cula

r are

a/fie

ld

Esta

blis

hmen

t of S

ubje

ct M

atte

r Ex

pert

(SM

E) P

rogr

amm

e in

ph

arm

acy

SME

prog

ram

est

ablis

hed

by 2

020

Initi

ativ

e 4:

Enha

nce

offic

ers’

cap

abilit

y to

car

ry o

ut a

nalys

is of

dig

ital

evid

ence

(Cyb

er F

oren

sic

Labo

rato

ry)

To c

ondu

ct a

spe

cial

trai

ning

with

ac

cred

ited

fore

nsic

age

ncy

Num

ber o

f offi

cers

und

ergo

trai

ning

an

d ce

rtifie

d10

0% o

ffice

rs c

ertifi

ed in

ad

vanc

ed le

vel

STRA

TEGY

2:

Optim

ise

Hum

an R

esou

rce

Capa

city

to E

nsur

e Co

ntin

uous

Ser

vice

Del

iver

y

Perc

enta

ge o

f MOH

faci

litie

s ac

hiev

ed m

ore

than

80%

pos

ts

fille

d80

%

Initi

ativ

e 1:

Deve

lop

Staf

fing

Guid

elin

es b

ased

on

faci

lity

wor

kloa

d

Iden

tifyi

ng th

e st

affin

g ne

eds

usin

g W

orkl

oad

Indi

cato

r for

Sta

ffing

Nee

ds

(WIS

N)

Staf

fing

guid

elin

es d

evel

oped

Staf

fing

guid

elin

es

deve

lope

d by

202

0

Initi

ativ

e 2:

Rede

ploy

men

t of p

harm

acy

staf

f to

ach

ieve

a b

alan

ced

WIS

N ra

tio

To e

nsur

e nu

mbe

r of f

acilit

ies

(hos

pita

l & h

ealth

clin

ics)

ach

ievi

ng

bala

nce

WIS

N ra

tio o

f 1 o

r agr

eed

ratio

(WIS

N ra

tio o

f 1 in

dica

tes

bala

nced

w

orkl

oad

and

man

pow

er)

Perc

enta

ge o

f fac

ility

achi

evin

g th

e ag

reed

ratio

or W

ISN

ratio

of 1

Mor

e th

an 7

5% o

f fac

ility

achi

eved

the

agre

ed ra

tio

or W

ISN

ratio

of 1


2017-202016

Pharmacy Policy and Strategic Planning Division would like to express gratitude and appreciation to the following participants for their support and contribution in the preparation of this document. The success and final outcome of this document required a lot of guidance and assistance from many people and we were extremely fortunate to have this all along until the completion of the document.

• Pharmacy Practice and Development Division• Pharmacy Enforcement Division• National Pharmaceutical Regulatory Agency (NPRA)• Pharmacy Board Malaysia• Deputy Director (Pharmacy) State Health Department • State Pharmacy Representatives

ACKNOWLEDGEMENT


2017-202018

www.pharmacy.gov.my

PHARMACEUTICAL SERVICES DIVISIONMinistry of Health MalaysiaLot 36, Jalan Universiti46350 Petaling JayaSelangor

T 03-7841 3200 F 03-7968 2222

PHARMACEUTICAL SERVICES DIVISIONMinistry of Health Malaysia

PHARMACYPROGRAMMESTRATEGIC PLAN

pharmacy€¦ · • empowering community • intensify collaboration this strategic plan was...

Documents